XML 72 R57.htm IDEA: XBRL DOCUMENT v3.22.4
Employee Benefit Plans - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
May 25, 2022
Mar. 31, 2022
Mar. 31, 2021
Dec. 30, 2022
Sep. 30, 2022
Oct. 01, 2021
Dec. 30, 2022
Dec. 31, 2021
Jan. 01, 2021
ESPP                  
Maximum potential to vest         25.00% 25.00%      
Expenses relating to stock match             $ 11.7 $ 9.5 $ 6.7
Amended and Restated 2017 Equity Incentive Plan                  
ESPP                  
Increase in share reserve under 2017 plan (in shares) 28,500,000                
Number of shares available for grant (in shares)       31,971,047     31,971,047    
Reduction in share reserve after stock option or stock appreciation award (in shares)             1    
Reduction in share reserve after all other awards (in shares)             2    
Minimum                  
ESPP                  
Number of months following change in control in which an employee was terminated             1 month    
Maximum                  
ESPP                  
Number of months following change in control in which an employee was terminated             13 months    
Stock options                  
ESPP                  
Expiration period             7 years    
Total unrecognized compensation expense       $ 16.6     $ 16.6    
Unrecognized compensation expense weighted-average period for recognition             2 years 2 months 12 days    
Intrinsic value of options exercised             $ 36.5 76.0 106.5
Cash received from option exercises and purchases under the ESPP             $ 13.9 $ 14.8 $ 26.9
Stock options | Share-based Payment Arrangement, Employee                  
ESPP                  
Award vesting period             4 years    
Stock options | Share-based Payment Arrangement, Nonemployee                  
ESPP                  
Award vesting period             1 year    
Restricted stock units                  
ESPP                  
Total unrecognized compensation expense       $ 183.6     $ 183.6    
Unrecognized compensation expense weighted-average period for recognition             2 years 10 months 24 days    
Number of awards granted (in shares)             7,933,000    
Number of awards (in shares)       11,294,000     11,294,000 6,828,000  
Restricted stock units | Share-based Payment Arrangement, Employee                  
ESPP                  
Award vesting period             4 years    
Restricted stock units | Share-based Payment Arrangement, Nonemployee                  
ESPP                  
Award vesting period             1 year    
TSR-Based Restricted Stock Units                  
ESPP                  
Number of awards granted (in shares)   1,003,482              
Maximum potential to vest   175.00%              
TSR-Based Restricted Stock Units | Share-based Payment Arrangement, Tranche One                  
ESPP                  
Award vesting period   1 year              
Vesting award percentage   50.00%              
ESPP                  
ESPP                  
Number of shares available for grant (in shares)       2,561,567     2,561,567    
Discount rate from market value on purchase date (as a percent)             85.00%    
Discount rate from market value on offering date (as a percent)             85.00%    
Purchase period             6 months    
Common stock issued (in shares)             606,787 536,226 534,419
Average price per share (in dollars per share)       $ 16.63     $ 16.63 $ 17.76 $ 14.55
Proceeds from employee stock purchase plan             $ 10.1 $ 9.5 $ 7.8
Performance stock units                  
ESPP                  
Award vesting period     1 year            
Unrecognized compensation expense weighted-average period for recognition             2 years 3 months 18 days    
Number of awards granted (in shares)     1,027,650       0    
Maximum potential to vest     200.00% 100.00%         200.00%
Additional shares to be earned (in shares)     2,055,300           4,655,680
Number of awards (in shares)       4,964,000     4,964,000 6,310,000  
Performance stock units | Achieved                  
ESPP                  
Number of awards (in shares)       869,502     869,502    
Performance stock units | Probable                  
ESPP                  
Total unrecognized compensation expense       $ 11.0     $ 11.0    
Performance stock units | Not Probable                  
ESPP                  
Total unrecognized compensation expense       $ 79.5     $ 79.5    
Performance stock units | Share-based Payment Arrangement, Tranche One                  
ESPP                  
Vesting award percentage     50.00%            
Performance Shares, Clinical Trial Results                  
ESPP                  
Number of awards granted (in shares)                 2,327,840